News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
215 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37191)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53928)
2023 (42568)
2024 (38486)
2025 (17535)
Month
January (2488)
February (2603)
March (3229)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
Business
Boehringer, MiNA Therapeutics Forge EUR 307M R&D NASH Tie-Up
Fresh off the heels of a $201M liver disease R&D deal with Dicerna, Boehringer Ingelheim has struck another deal targeting liver disease with MiNA Therapeutics.
November 8, 2017
·
2 min read
·
Alex Keown
Why Teva’s Stock Could Crash Another 50%
Teva continues to be battered by its massive debt load and struggling pipeline.
November 8, 2017
·
2 min read
·
Alex Keown
Business
Boston Scientific to Expand Its Ireland Facility
A masterplan is currently being prepared with options for the expansion of the company in Galway.
November 8, 2017
·
1 min read
Genetown
Cambridge’s Exonics Therapeutics Scores $40M
Exonics Therapeutics closed on a $40M Series A financing which was led by The Column Group.
November 8, 2017
·
2 min read
·
Mark Terry
Policy
Editas CEO to Testify at a U.S. Senate Hearing Next Week
The hearing will focus on the therapeutic potential and ethical issues of using CRISPR technology to alter human DNA.
November 8, 2017
·
1 min read
Business
Micropulse Expansion to Create New Jobs
The company will invest $5.5 million to boost its machining and inspection capacity, creating 25 jobs.
November 8, 2017
·
1 min read
Drug Development
Five Prime Tanked on Early Peek of Lead Drug Data
Five Prime stock took a beating after it unintentionally released Phase Ia/Ib clinical trial of its CSF-1R antibody cabiralizumab with BMS’ Opdivo (nivolumab).
November 8, 2017
·
3 min read
·
Mark Terry
Business
How This Medical Device Startup is Taking a Fresh Look at Healthcare
Despite the promise of technology-driven innovations, one industry that arguably is slow to adapt to these trends is the medical device industry.
November 8, 2017
·
1 min read
Biotech Bay
Bay Area’s Tricida Closes $57.5M Series D, Pushes Into Phase III Trial
Proceeds will be used to complete the ongoing pivotal TRCA-301 Phase 3 clinical trial of TRC101.
November 8, 2017
·
3 min read
·
Mark Terry
Biotech Bay
Top 5 Best Biotechs That Could Beat Estimates in Q3
The Q3 earnings season is approaching its end with 81.2% of the S&P 500 companies having already released results.
November 8, 2017
·
1 min read
1 of 22
Next
